The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

被引：0
作者：
V. ten Cate
H. ten Cate
F. W. A. Verheugt
机构：
[1] Cardiovascular Research Institute Maastricht,Laboratory for Clinical Thrombosis and Haemostasis
[2] Cardiovascular Research Institute Maastricht,Department of Internal Medicine
来源：
Netherlands Heart Journal | 2016年 / 24卷
关键词：
Atrial fibrillation; Anticoagulants; Stroke; Netherlands; Registries;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There are over 385,000 cases of atrial fibrillation (AF) in the Netherlands, with over 45,000 new cases each year. Among other things, AF patients are at high risk of stroke. Patients are often prescribed oral anticoagulation, such as vitamin K antagonists (VKA), to mitigate these risks. A recently introduced class of oral anticoagulants, non-vitamin K antagonists (NOAC), is quickly gaining currency in global clinical practice. This study provides insight into the changes these new drugs will bring about in Dutch clinical practice.
引用
收藏
页码：574 / 580
页数：6
相关论文
共 60 条
  • [1] Heemstra HE(2011)The burden of atrial fibrillation in the Netherlands Neth Heart J 19 373-378
  • [2] Nieuwlaat R(2013)A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin Int Arch Med 6 46-2375
  • [3] Meijboom M(2001)Prevalence of diagnosed atrial fibrillation in adults J Am Med Assoc 285 2370-510
  • [4] Crijns HJ(2010)Thromboembolism in atrial fibrillation Am J Cardiol 105 502-304
  • [5] Stambler BS(2008)Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data Thromb Haemost 99 295-19.e1
  • [6] Go A(2012)International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) Am Heart J 163 13-2221
  • [7] Hylek E(2013)Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with Nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups Thromb J 2013 Article ID 640723-198
  • [8] Phillips K(2007)In defense of pharmacoepidemiology – embracing the Yin and Yang of drug research N Engl J Med 357 2219-2033
  • [9] Menke J(2013)An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol BMC Cardiovasc Disord 13 31-2106
  • [10] Lüthje L(2013)INR control calculation: comparison of dutch and international methods Neth J Med 71 194-278
123456